TaurActive (Taurine)

Taurine is a sulfonic amino acid that functions as an osmoregulator and membrane stabilizer, modulating intracellular calcium handling and chloride ion transport across cell membranes. TaurActive delivers taurine as the bioactive compound, leveraging its roles in conjugating bile acids, supporting mitochondrial function, and regulating neurological and cardiovascular cell homeostasis.

Origin & History

TaurActive contains taurine, a naturally occurring amino sulfonic acid (2-aminoethanesulfonic acid) first isolated from ox bile in 1827. It is biosynthesized in human liver and pancreas from cysteine via the cysteine sulfinic acid pathway, though commercial taurine is chemically synthesized through ammonolysis of isethionic acid or aziridine reactions rather than extracted from organisms.

Historical & Cultural Context

No historical or traditional medicinal uses are documented in the research. Taurine was identified scientifically in 1827 from ox bile without any prior traditional medicine context.

Health Benefits

• Limited clinical evidence available - research dossier contains no specific RCTs or clinical trials
• FDA-approved component in hypertonic amino acid injections since 1984 (regulatory approval only)
• Theoretical roles in fluid regulation and membrane stabilization based on biochemical properties
• Potential involvement in bile salt interactions due to chemical structure
• Essential biological processes noted but without clinical trial support

How It Works

Taurine acts as an organic osmolyte by regulating intracellular volume through modulation of chloride channels, particularly GABA-A receptor-linked channels, influencing neuronal excitability. It conjugates with bile acids to form taurocholic and taurochenodeoxycholic acids, facilitating hepatic lipid metabolism and cholesterol clearance. Additionally, taurine stabilizes mitochondrial membrane potential by scavenging reactive oxygen species and interacting with the mitochondrial tRNA modification pathway via the formation of 5-taurinomethyluridine, which is critical for mitochondrial protein synthesis.

Scientific Research

The research dossier explicitly states that search results lack specific details on key human clinical trials, RCTs, or meta-analyses for taurine, with no PubMed PMIDs, study designs, or clinical outcomes provided. While general references note its abundance in organs and FDA approval for injection formulations since 1984, no specific clinical trial data is available in the provided sources.

Clinical Summary

Clinical evidence specifically supporting TaurActive as a branded ingredient is currently absent from published literature, with no randomized controlled trials or controlled clinical studies identified in its research dossier. Broader taurine research includes small-scale trials — often 20 to 60 participants — examining cardiovascular outcomes, exercise performance, and metabolic markers, but effect sizes and methodologies vary considerably, limiting generalizability. Taurine received FDA approval as a component in hypertonic amino acid parenteral nutrition solutions in 1984, reflecting established safety in clinical nutrition rather than efficacy for energy supplementation per se. Overall, the current evidence base for taurine's energy-boosting claims is theoretical and biochemically plausible but not yet confirmed by robust, large-scale human RCTs.

Nutritional Profile

Taurine (TaurActive) is a non-proteinogenic sulfonic amino acid (2-aminoethanesulfonic acid), not incorporated into proteins and therefore not a traditional macronutrient contributor. Molecular weight: 125.15 g/mol. Contains sulfur (~25.6% by molecular weight), nitrogen (~11.2%), and no caloric value (0 kcal/g) as it is not metabolized via standard amino acid catabolism pathways. Not a source of vitamins, minerals, or dietary fiber. Endogenous synthesis occurs in humans from cysteine and methionine via cysteine sulfinic acid decarboxylase pathway, though synthetic capacity is limited (~50-125 mg/day endogenous production). Dietary sources typically provide 40-400 mg/day, predominantly from meat, seafood, and dairy (e.g., scallops: ~827 mg/100g; dark chicken meat: ~169 mg/100g; cow's milk: ~6 mg/100g). As a free amino acid, oral bioavailability is high (estimated >80%), absorbed via taurine-specific transport proteins (TauT/SLC6A6) in the small intestine. Plasma concentrations in supplemented individuals typically reach 100-200 nmol/mL at doses of 1-3 g/day. Distributed widely in tissues with highest concentrations in heart, skeletal muscle, retina, and brain. Renal reabsorption is efficient at physiological doses, with urinary excretion increasing dose-dependently at supplemental levels. Contains no fiber, no measurable caloric density, no vitamins, and no traditional mineral content beyond its intrinsic sulfur.

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are available in the research dossier. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research data to recommend synergistic compounds

Safety & Interactions

Taurine is generally regarded as safe at typical supplemental doses of 500 mg to 3,000 mg per day, with no serious adverse effects reported in healthy adults at these levels in short-term studies. High-dose taurine may potentiate the effects of GABAergic medications such as benzodiazepines or anticonvulsants due to its activity at GABA-A receptors, and caution is warranted when combining with lithium, as taurine may increase renal lithium excretion. Individuals with chronic kidney disease should consult a physician before supplementing, as impaired renal clearance may alter taurine metabolism and accumulation. Safety data in pregnancy and lactation is insufficient, and use is not recommended in these populations without direct medical supervision.